Navigation Links
MiMedx Announces 2012 Results
Date:3/7/2013

business, and the expected quarterly revenue growth. These statements are based on current information and belief, and are not guarantees of future performance.  Among the risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements include that the direct sales force strategy will not continue to produce quarter-over-quarter sales growth, that the clinical study results will not be as positive as anticipated or will not enable the Company to capture additional market presence, that a new patent will not issue in the near term  or that the claims, if any, allowed will be substantially reduced, that competitors can "design around" the Company's patents; that the Company may not be successful in entering into new placenta recovery contracts, that the Company's existing and future placental recovery contracts will not be sufficient to meet the Company's demand for tissue,  that the reimbursement coverage in the Medicare and commercial sectors does not materialize or expands at a rate slower than anticipated, that VA and government business will not continue to increase, that quarterly revenue growth will be below expectations, and the risk factors detailed from time to time in the Company's periodic Securities and Exchange Commission filings, including, without limitation, its 10-K filing for the fiscal year ended December 31, 2011. By making these forward-looking statements, the Company does not undertake to update them in any manner except as may be required by the Company's disclosure obligations in filings it makes with the Securities and Exchange Commission under the federal securities laws.

 MIMEDX GROUP, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF OPERATIONS Years Ended December 31,REVENUES:20122011Net sales$
27,053,773$
7,760,446OPERATING COSTS AND EXPENSES:Cost of products sold

5,188,3783,357,909Research and development expenses

'/>"/>
SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. MiMedx Group to Present at the 6th Annual OneMedForum
2. MiMedx Group to Present at the Stifel Nicolaus 2012 Healthcare Conference
3. CCS Medical Announces Agreement with LifeScan
4. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
5. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Impax Laboratories Inc.
7. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
8. DMH International Announces The Launch of TouchPACS
9. Psyche Systems Announces Availability of Toxicology LIS
10. Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders
11. DDS Lab Announces Strategic Alliance with United Concordia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... WASHINGTON , May 22, 2015  The ... certain diagnosed victims of mesothelioma get the best ... making certain individuals with this rare cancer caused ... the most up-to-date information related to treatment options ... information please call the Mesothelioma Victims Center anytime ...
(Date:5/22/2015)... --  InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the ... announced that its CGuard TM Embolic Prevention System reported ... Piotr Musialek , at the EuroPCR conference on ... PARADIGM, an investigator-initiated P rospective evaluation of ... revascularization I n symptomatic and increased-risk asymptomatic carotid ...
(Date:5/22/2015)... , May 22, 2015  In a sweeping ... the U.S., T1D Exchange researchers conclude that ... type 1 diabetes across all age groups, but especially ... most up-to-date picture of diabetes treatment, underscoring the need ... and technologies that can help type 1 patients achieve ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... In a platform presentation at the 46th annual meeting ... (EASD) in Stockholm, investigators for Biodel Inc. (Nasdaq: ... clinical study evaluating a new pH-neutral formulation of Linjeta™ ... Research, Neuss, Germany) and colleagues reported that the new ...
... (Nasdaq: MYL ) today announced that its ... the U.S. Food and Drug Administration (FDA) for its ... mg, 1 mg and 5 mg, the generic version ... in people who have received certain organ transplants. ...
Cached Medicine Technology:Results of Linjeta™ Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting 2Results of Linjeta™ Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting 3
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health ... health brand Nature’s Way, Marc St-Onge has affirmed his ... Skin is an integral part of the agreement with ... to further develop Ascenta Skin into a leading player ... a breakthrough, anti-aging skincare supplement featuring 6 active ingredients ...
(Date:5/22/2015)... “It’s like learning an new language,” ... President of Clinical Operations/Education and Training at Harmony ... how care is coded and reimbursed.” , Harmony ... reimbursement, operations and compliance consulting, as well as ... a new series of day-long seminars on the ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the beginning of vacation ... to help promote safe travel. , According to estimates from ... this Memorial Day weekend. Amica is sharing the following road ... , , Always wear a seatbelt: Make ... they’re driving or riding along as a passenger. Seatbelts are ...
(Date:5/22/2015)... ZH Healthcare (ZH), a ... that Bill Lane, joins ZH’s Advisory Board. ... first of its kind, Freemium SaaS, Electronic Health ... Records (EHR) with an integrated practice management system ... portal, and more. Combined with its Revenue Cycle ...
(Date:5/22/2015)... 2015 Medivo, Inc., a leader in lab ... Genotype Results in ‘Baby Boomers’ Screened for HCV Following the ... Test Database” at Digestive Disease Week, May 16-19, 2015. ... Analytics team members Carol Smyth, MB; Jason Bhan, MD; Tatiana ... along with Nancy Reau, MD from the University of Chicago, ...
Breaking Medicine News(10 mins):Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2
... children which are permissible under Islam was a key ... of an inaugural health conference for OIC nations . ... of the Islamic Conference's 57 member nations, along with ... issues including polio vaccination, preparedness for bird flu outbreaks ...
... sleep deprivation can do more than leave you short-tempered: ... risk of cardiovascular disease and death, according to a ... and behavioural effects of long-term sleep loss have been ... poor mood. But the study by researchers at the ...
... ironing or washing up may reduce the risk of ... ,Researcher Genevieve Healy said while helping ... 30 minutes of daily exercise recommended by health authorities, ... level. High glucose levels are associated with diabetes and ...
... has decided to investigate the frequency of breast cancer among ... ,The move followed the release today of a ... high rate of breast cancer cases at its studios in ... there is a currently unknown or undetected aspect of work ...
... knows we need them here" ... Organ donor families was held at the Durbar Hall of ... MOHAN (Multi-Organ Harvesting And Networking) Foundation to felicitate the commendable contributions of ... few. The function was graced by the presence of the governor, Dr. ...
... developed the next generation of self healing material, which ... . ,According to Nancy Sottos, a Willett ... author of a paper detailing the research, the new ... biological circulatory systems. ,In the researchers original ...
Cached Medicine News:Health News:Child Vaccines a Key Issue for OIC Forum in Malaysia 2Health News:Insufficient Sleep Increases Risk of Cardiovascular Disease: Study 2Health News:Australian TV Channel to Study Breast Cancer Incidence in Its Women Staff 2Health News:Life After Death: Organ Donation 2Health News:Life After Death: Organ Donation 3Health News:Researchers Develop Material That Self Heals Like Human Skin 2
... Sling System utilizes a suprapubic approach ... due to urethral hypermobility and/or intrinsic ... curved, narrow-diameter needles and a self-fixating ... that allows for intra-operative tension refinement ...
... The In-Fast™ Ultra Sling is a minimally ... A concomitant repair surgery can be performed ... an abdominal incision.To place a sling, the ... two small titanium bone screws into the ...
... technology marries with the well-researched ... sling, for exceptional resultsby design. ... and host, reduces the potential ... or erosion and provides secure ...
... Delivers the durability of natural ... benefits of ingrowth and natural ... or exceeds all applicable state ... Allograft Tissue also reduces OR ...
Medicine Products: